Our research

Reprogramming immune cells to fight cancer
Dr Claire Roddie make the case for CAR-T cells being 'the best medicine'.

£8m funding boost to accelerate brain tumour research
The CRUK Glioma Centre of Excellence, a joint initiative between UCL and the University of Edinburgh, is researching how glioblastoma starts, evolves and evades existing treatments

Transforming radiotherapy
Advancing Proton Beam research and therapy at UCL / UCLH
Research departments
- Cancer Biology - Dept. Head: Professor Simona Parrinello
- Clinical Trials - Dept. Head: Professor Allan Hackshaw
- Haematology - Dept. Head: Professor Kwee Yong
- Oncology - Dept. Head: Professor Daniel Hochhauser
- Pathology - Dept. Head: Professor Adrienne Flanagan
Centres and networks
- Bill Lyons Informatics Centre
- Cancer Immunotherapy Accelerator (CITA)
- Cancer Research UK City of London Centre
- Cancer Research UK Brain Tumour Centre of Excellence
- Cancer Research UK Lung Cancer Centre of Excellence
- Comprehensive Cancer Imaging Centre
- Experimental Cancer Medicine Centre
- The Medical Research Council Laboratory for Molecular Cell Biology (MRC LMCB)
- NIHR Blood and Transplant Research Unit - Stem Cells and Immunotherapies
UCL CAR T cell Programme
The UCL CAR T cell programme is based in the Cancer Institute and coordinates developing and testing of new engineered T cell therapies.
Cancer Institute Translational Technology Platforms
The Cancer Institute Translational Technology Platforms provide scientific infrastructure for cutting edge basic, translational and clinical cancer services to support cancer researchers at UCL.